Role of genetic mutations in vascular access thrombosis among hemodialysis patients waiting for renal transplantation
Authors:
- 17 September 2002
- journal article
- research article
- Published by Elsevier in Transplantation Proceedings
- Vol. 34 (6) , 2030-2032
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Role of hemostatic gene polymorphisms in venous and arterial thrombotic diseaseBlood, 2000
- Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patientsKidney International, 1999
- Prothrombin gene 20210 G-A mutation in the Turkish populationAmerican Journal of Hematology, 1998
- Venous Thrombosis — The Interaction of Genes and EnvironmentNew England Journal of Medicine, 1998
- Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistulaNephrology Dialysis Transplantation, 1996
- Correlates of Vascular Access Occlusion in HemodialysisAmerican Journal of Kidney Diseases, 1994
- Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor VThe Lancet, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Hemorheology and Fistula Function in Home Hemodialysis Patients following Erythropoietin Treatment: A Prospective Placebo-Controlled StudyNephron, 1993
- The Impact of Diagnosis-Related Groups on the Cost of Hospitalization for End-Stage Renal Disease Patients at Rhode Island Hospital From 1987 to 1990American Journal of Kidney Diseases, 1992